Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.

MLA

Atwell, Graham J., et al. “Synthesis and Structure-Activity Relationships for 2,4-Dinitrobenzamide-5-Mustards as Prodrugs for the Escherichia Coli NfsB Nitroreductase in Gene Therapy.” Journal of Medicinal Chemistry, vol. 50, no. 6, Mar. 2007, pp. 1197–212. EBSCOhost, https://doi.org/10.1021/jm061062o.

APA

Atwell, G. J., Yang, S., Pruijn, F. B., Pullen, S. M., Hogg, A., Patterson, A. V., Wilson, W. R., & Denny, W. A. (2007). Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy. Journal of Medicinal Chemistry, 50(6), 1197–1212. https://doi.org/10.1021/jm061062o

Chicago

Atwell, Graham J, Shangjin Yang, Frederik B Pruijn, Susan M Pullen, Alison Hogg, Adam V Patterson, William R Wilson, and William A Denny. 2007. “Synthesis and Structure-Activity Relationships for 2,4-Dinitrobenzamide-5-Mustards as Prodrugs for the Escherichia Coli NfsB Nitroreductase in Gene Therapy.” Journal of Medicinal Chemistry 50 (6): 1197–1212. doi:10.1021/jm061062o.